Mode
Text Size
Log in / Sign up
N/A N=110 Randomized Treatment

Weight Management for Adolescents With IDD

Developmental Disabilities · Weight Loss · Body Weight · Down Syndrome · Body Weight Changes

Enrolled (actual)
110
Serious AEs
0.9%
Results posted
Feb 2023
Primary outcome: Primary: Weight Change at 6 Months — -0.3; -1.8; -5.0 kg

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Enhanced Stop Light Diet (eSLD) (Dietary_supplement); Conventional Diet (CD) (Dietary_supplement); Face-to-face (FTF) (Behavioral); Technology (TECH) (Behavioral); iPad with FaceTime (Other)
Age
Pediatric, Adult · 13+ yrs
Sex
All
Sponsor
University of Kansas Medical Center
Primary completion
May 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Weight Change at 6 Months
-0.3; -1.8; -5.0
SECONDARY
Weight Change Across 18 Months
1.4; -0.2; -2.2

Summary

The goal of this study is to explore the impact of two different diets (conventional vs. enhanced stop light) and two different delivery systems (face-to-face vs. remote) on weight across 18 months in overweight and obese adolescents with intellectual and developmental disabilities.

Eligibility Criteria

Inclusion Criteria

  • Age 13-21 yrs
  • Mild (IQ of 74-50) or moderate (IQ 40-49) IDD,
  • Of sufficient functional ability to understand directions, communicate preferences (e.g. foods), wants (e.g. more to eat/drink), and needs (e.g. assistance with food preparation) through spoken language.
  • Overweight or obese (BMI ≥ 85th%ile on CDC growth charts, or waist circumference to height ratio > 0.5
  • Living at home with a parent or guardian.
  • Internet access in the home.
  • No plans to relocate outside the study area over the next 18 mos
  • Physician consent for PA and diet.

Exclusion Criteria

  • Insulin dependent diabetes
  • Participation in a weight management program involving diet and PA in the past 6 mos
  • Eating disorders, serious food allergies, consuming special diets, aversion to common foods,
  • Diagnosis of Prader-Willi Syndrome
  • Currently pregnant, planning on/becoming pregnant during the study.
  • Unable to participate in moderate to vigorous PA.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02561754). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search